Page last updated: 2024-08-21

isoxazoles and dactolisib

isoxazoles has been researched along with dactolisib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, PM; Chao, Y; Chen, MH; Chen, TW; Chen, YY; Cheng, CT; Chiang, KC; Huang, CY; Huang, SC; Jan, YY; Li, CP; Liu, CY; Wang, HM; Weng, JJ; Yeh, CN; Yeh, TS1

Other Studies

1 other study(ies) available for isoxazoles and dactolisib

ArticleYear
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
    Oncotarget, 2014, May-15, Volume: 5, Issue:9

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Cell Proliferation; Cholangiocarcinoma; Female; Flow Cytometry; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Imidazoles; Immunoenzyme Techniques; Isoxazoles; Male; Membrane Potential, Mitochondrial; Middle Aged; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinolines; Rats; Rats, Sprague-Dawley; Resorcinols; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2014